Now Available: PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and ... ClickPress (press release) [ClickPress, Tue Jun 18 2013] GlobalData has released its pharma report, "PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the ...
"Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline ... SBWire (press release) This report provides information on the therapeutic development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
Research and Markets: PharmaPoint: Chronic Myeloid Leukemia (CML) - France ... Business Wire (press release) GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) - France Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the ...
New Drug Target Identified For Treating Deadly Form Of Leukemia Asian Scientist Magazine 4, 2013) – A research team in Singapore has identified ways to inhibit the function of a key protein linked to stem cell-like behavior in terminal-stage chronic myeloid leukemia (CML). The discovery makes it possible to develop drugs that may extend ...
Research and Markets: PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy ... Fort Mills Times GlobalData has released its new Country report, PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy Drug Forecast and Market Analysis to 2022. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the ...